Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 4911-4914, August 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Victor, T.
Right arrow Articles by van Helden, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Victor, T.
Right arrow Articles by van Helden, P. D.

No Evidence for Point Mutations in Codons 12, 13, and 61 of the ras Gene in a High-Incidence Area for Esophageal and Gastric Cancers1

T. Victor2, R. Du Toit, A. M. Jordaan, A. J. Bester and P. D. van Helden3

MRC Centre for Molecular and Cellular Biology, Department of Medical Physiology and Biochemistry, University of Stellenbosch Medical School, P.O. Box 63, Tygerberg, 7505 Republic of South Africa

The molecular mechanisms underlying the induction of esophageal and gastric cancer are not yet understood. It is possible that different etiological factors from geographically distinct areas play a role in the onset of these cancers. Twenty-seven primary esophageal and 11 gastric cancers originating from the high-incidence areas of South Africa were analyzed for the presence of ras protooncogene mutations. We found no evidence for mutations in codons 12, 13, or 61 or the H-ras, K-ras, and N-ras genes in these primary cancers.

Our results indicate that etiological factors such as fungal contamination of basic foodstuffs in a high-incidence area for these cancers do not play a role in the activation of ras genes and that mutations in these genes are not directly involved in the development of primary esophageal and gastric cancers in the South African population.

1 This paper is part of a Ph.D. thesis.

2 To whom requests for reprints should be addressed.

3 Partially funded by a grant to P.D.v.H. from the National Cancer Association of South Africa.

Received 8/29/89. Revised 4/16/90.


This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Z. Fang, C. Liu, Y. Song, G.-Y. Yang, Y. Nie, J. Liao, X. Zhao, Y. Shimada, L.-D. Wang, and C. S. Yang
Over-expression of gastrin-releasing peptide in human esophageal squamous cell carcinomas
Carcinogenesis, June 1, 2004; 25(6): 865 - 871.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Y. Y. Fong, H. Ishii, V. T. Nguyen, A. Vecchione, J. L. Farber, C. M. Croce, and K. Huebner
p53 Deficiency Accelerates Induction and Progression of Esophageal and Forestomach Tumors in Zinc-deficient Mice
Cancer Res., January 1, 2003; 63(1): 186 - 195.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.